Experimental results indicated that SLC6A19 could inhibit invasion and proliferation of ccRCC cells and GSEA pinpointed that SLC6A19 was intimately correlated with fatty acid metabolism and CPT1A. The gene discussed is CPT1A; the disease is nonpapillary renal cell carcinoma.